MHRA Recalls Ramipril 10mg Batch Over Dosage Error

The Medicines and Healthcare products Regulatory Agency has issued a recall for a specific batch of Ramipril 10mg capsules after discovering a manufacturing error that could result in some packages containing a lower dose of the medication. The alert, announced on Monday, affects products distributed primarily in 2025 and urges patients and healthcare providers across the United Kingdom to verify their supplies immediately.

Crescent Pharma Limited, the manufacturer, is withdrawing batch number GR174091 as a precautionary measure. The issue stems from a packaging mistake at the production site, where one blister pack of Ramipril 5mg capsules from batch GR164091 was found inside a sealed carton intended for the 10mg strength. This error occurred during the secondary packaging process, and only one such complaint has been reported to date. The MHRA has classified the recall as Class 2, targeting patients, pharmacies, and wholesalers.

Healthcare professionals have been directed to halt distribution of the affected batch, quarantine any remaining stock, and return it to suppliers. Where batch traceability is available, they must contact patients who received the product and request...